Alligator Bioscience AB: Year End report January-December 20

STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving Forward "During the fourth quarter 2021, Alligator reached several key milestones in our pre-clinical

Related Keywords

Sweden , Rotterdam , Zuid Holland , Netherlands , Stockholm , United Kingdom , Swedish , Julie Silber , Marie Svensson , Aptevo Therapeutics Inc , Shanghai Henlius Biotech Inc , Macrogenics Inc , Erasmus Mc University Medical Center Rotterdam , Abclon Inc , Orion Corporation , Biotheus Inc , Shanghai Henlius Biotech , Medical Center Rotterdam , Aptevo Therapeutics , Rights Issue , Alligator Bioscience , Swedish Securities Markets , Nasdaq Stockholm , Year End , Alligator , Ioscience , Ear , Eport , Anuary , Ecember , 021 ,